In vivo experiments showed that global Prrx1 inhibition using a Prrx1-targeting antisense oligonucleotide (ASO) significantly attenuated fibrosis in the murine bleomycin model of pulmonary fibrosis (Marchal-Duval et al., 2023). The gene discussed is PRRX1; the disease is pulmonary fibrosis.